- Home
- MVST vs KOD Comparison
MVST vs KOD Comparison
Compare MVST & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVST | KOD |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 848.0M | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MVST | KOD |
|---|---|---|
| Price | $3.71 | $24.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $6.00 | ★ $22.29 |
| AVG Volume (30 Days) | ★ 5.4M | 755.1K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $444,504,000.00 | N/A |
| Revenue This Year | $24.14 | N/A |
| Revenue Next Year | $28.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.82 | N/A |
| 52 Week Low | $1.06 | $1.92 |
| 52 Week High | $7.12 | $24.56 |
Technical Indicators
Market Signals| Indicator | MVST | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 69.37 |
| Support Level | $3.28 | $21.24 |
| Resistance Level | $3.57 | $23.63 |
| Average True Range (ATR) | 0.24 | 1.99 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 69.35 | 98.13 |
Price Performance
Historical ComparisonAbout MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.